Increased Serum Levels of Interleukin-9 Correlate to Negative Prognostic Factors in Hodgkin's Lymphoma

Leukemia - United Kingdom
doi 10.1038/sj.leu.2403123
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Serum YKL-40 and Interleukin 6 Levels in Hodgkin Lymphoma

Clinical Cancer Research
Cancer ResearchOncology
2008English

Increased Urinary Interleukin 22 Binding Protein Levels Correlate With Lupus Nephritis Activity

Journal of Rheumatology
RheumatologyAllergyImmunology
2014English

Evaluation of Serum CEA and CA19-9 Levels as Prognostic Factors in Patients With Gastric Cancer

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2000English

Prognostic Significance of Interleukin 6 Serum Levels in Patients With Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
1995English

Prognostic Factors in Aggressive Non‐Hodgkin's Lymphomas

Oncologist
Cancer ResearchMedicineOncology
1998English

A Critical Analysis of Prognostic Factors for Survival in Intermediate and High Grade Non-Hodgkin's Lymphoma

British Journal of Cancer
Cancer ResearchOncology
1991English

Increased Serum Levels of Interleukin-10 Predict Poor Prognosis in Extranodal Natural Killer/T-Cell Lymphoma Patients Receiving Asparaginase-Based Chemotherapy

OncoTargets and Therapy
OncologyPharmacology
2015English

Prognostic Factors in Follicular Lymphoma

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2010English

The Negative Prognostic Significance of Serum Immunoglobulin Paraprotein in Patients With Diffuse Large B Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy